Cannabis is a very controversial plant and there is a lack of enough clinical studies to further prove its medical impact. Researchers are busy with new studies with promising results. Certain mental health conditions can be effectively treated with cannabis.
More info on the use of CBD
The cannabis-derived chemical cannabidiol (CBD) has been proved to offer relief for patients suffering from schizophrenia. This chronic condition interferes in the way people think, feel and behave.
The study has been made by researchers from the University of Wollongong who discovered that CBD provides symptom relief for schizophrenia. The CDB has an impact on the patient’s cognitive function.
A group of researchers, Dr. Katrina Green, Professor Nadia Solowij and PhD candidate Ashleigh Osborne, has conducted a study involving the detailed review of 27 prior researches which were made about CDB. The study has uncovered proof of its therapeutic value.
CDB is put to test
Following the study, Dr. Green decided to test the BD and for that she collaborated with Senior Professor Xu-Feng Huang and PhD candidate Ilijana Babic. Their results were promising.
Chronic administration of CBD improved schizophrenia symptoms. One of the symptoms was cognitive deficit. The study was done on rats suing prenatal poly I:C infection.
The team of specialists declared that their research proved that CBD id able to restore recognition and working memory and improves social behavior to normal levels. It is also important to specify that the cannabis treatments did not alter body weight or food intake. These are common side effects of traditional antipsychotic drug treatment.
The study has excellent news since current antipsychotic drugs do not help with the cognitive deficits and this symptom is encountered in 80% of patients with schizophrenia. The same use of cannabis has also shown to treat the Tourette syndrome, which is characterized by involuntary physical and verbal tics.